Federal Register / Vol. 75, No. 98 / Friday, May 21, 2010 / Notices 28625 

Contact Person: Eileen W Bradley, DSC, 

Chief, SBIB IRG, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5100, MSC 7854, Bethesda, MD 

20892, (301) 435–1179, bradleye@csr.nih.gov. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group, Aging Systems and Geriatrics Study 

Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Allerton Hotel, 701 North Michigan 

Avenue, Chicago, IL 60611. 

Contact Person: James P. Harwood, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5168, 

MSC 7840, Bethesda, MD 20892, 301–435– 

1256, harwoodj@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, 

Integrative Nutrition and Metabolic Processes 

Study Section. 

Date: June 14, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Sooja K Kim, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6182, 

MSC 7892, Bethesda, MD 20892, (301) 435– 

1780, kims@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group, 

Prokaryotic Cell and Molecular Biology 

Study Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz Carlton Hotel, 1150 22nd Street, 

NW., Washington, DC 20037. 

Contact Person: Diane L. Stassi, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3202, 

MSC 7808, Bethesda, MD 20892, 301–435– 

2514, stassid@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group, 

Pathobiology of Kidney Disease Study 

Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Chicago O’Hare Airport, 

O’Hare International Airport, Chicago, IL 

60666. 

Contact Person: Mushtaq A. Khan, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2176, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1778, khanm@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group, Clinical Oncology Study Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Malaya Chatterjee, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6192, 

MSC 7804, Bethesda, MD 20817, (301) 806– 

2515, chatterm@csr.nih.gov. 

Name of Committee: Oncology 1–Basic 

Translational Integrated Review Group, 

Cancer Etiology Study Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Washington, 1515 

Rhode Island Avenue, NW., Washington, DC 

20005. 

Contact Person: Cathleen L Cooper, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4208, 

MSC 7812, Bethesda, MD 20892, 301–443– 

4512, cooperc@csr.nih.gov. 

Name of Committee: Vascular and 

Hematology Integrated Review Group, 

Vascular Cell and Molecular Biology Study 

Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: InterContinental Chicago Hotel, 505 

North Michigan Avenue, Chicago, IL 60611. 

Contact Person: Anshumali Chaudhari, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4124, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1210, chaudhaa@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR10–082: 

Shared Equipment for Macromolecular X-ray 

and Light Scattering. 

Date: June 14–15, 2010. 

Time: 8:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: David R. Jollie, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4150, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1722, jollieda@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Clinical and 

Research Ethics. 

Date: June 14–15, 2010. 

Time: 9 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Karin F. Helmers, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3166, 

MSC 7770, Bethesda, MD 20892, 301–254– 

9975, helmersk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ARRA: 

Motor Function, Speech and Rehabilitation 

Competitive Revisions. 

Date: June 14, 2010. 

Time: 4 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Old Town Alexandria, 

901 North Fairfax Street, Alexandria, VA 

22314. 

Contact Person: Biao Tian, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3089B, MSC 7848, Bethesda, 

MD 20892, (301) 402–4411, 

tianbi@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 14, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12154 Filed 5–20–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Assessment of 

Post-Treatment Lyme Disease 

Syndrome, Funding Opportunity 

Announcement (FOA) CK10–004, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 12:30 p.m.–4:30 p.m., June 

23, 2010 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Assessment of Post-Treatment 

Lyme Disease Syndrome,’’ FOA CK10–004. 

Contact Person for More Information: 

Maurine Goodman, MA, MPH, Scientific 

Review Administrator, CDC, 1600 Clifton 

Road, NE., Mailstop D72, Atlanta, GA 30333, 

Telephone: (404) 639–4737. 


emcdonald on DSK2BSOYB1PROD with NOTICES
28626 Federal Register / Vol. 75, No. 98 / Friday, May 21, 2010 / Notices 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: May 6, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–12169 Filed 5–20–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Subcommittee on Procedures Review, 

Advisory Board on Radiation and 

Worker Health (ABRWH), National 

Institute for Occupational Safety and 

Health (NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

aforementioned subcommittee: 

Time and Date: 9:30 a.m.–5 p.m., June 

8, 2010. 

Place: Cincinnati Airport Marriott, 

2395 Progress Drive, Hebron, Kentucky 

41018, Telephone: (859) 334–4611, Fax: 

(859) 334–4619. 

Status: Open to the public, but 

without a public comment period. To 

access by conference call dial the 

following information: (866) 659–0537, 

Participant Pass Code 9933701. 

Background: The ABRWH was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

compensation program. Key functions of 

the ABRWH include providing advice 

on the development of probability of 

causation guidelines that have been 

promulgated by the Department of 

Health and Human Services (HHS) as a 

final rule; advice on methods of dose 

reconstruction which have also been 

promulgated by HHS as a final rule; 

advice on the scientific validity and 

quality of dose estimation and 

reconstruction efforts being performed 

for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special 

Exposure Cohort (SEC). 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the ABRWH to 

HHS, which subsequently delegated this 

authority to CDC. NIOSH implements 

this responsibility for CDC. The charter 

was issued on August 3, 2001, renewed 

at appropriate intervals, and will expire 

on August 3, 2011. 

Purpose: The ABRWH is charged with 

(a) Providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) 

providing advice to the Secretary, HHS, 

on the scientific validity and quality of 

dose reconstruction efforts performed 

for this program; and (c) upon request 

by the Secretary, HHS, advising the 

Secretary on whether there is a class of 

employees at any Department of Energy 

facility who were exposed to radiation 

but for whom it is not feasible to 

estimate their radiation dose, and on 

whether there is a reasonable likelihood 

that such radiation doses may have 

endangered the health of members of 

this class. The Subcommittee on 

Procedures Review was established to 

aid the ABRWH in carrying out its duty 

to advise the Secretary, HHS, on dose 

reconstructions. The Subcommittee on 

Procedures Review is responsible for 

overseeing, tracking, and participating 

in the reviews of all procedures used in 

the dose reconstruction process by the 

NIOSH Division of Compensation 

Analysis and Support (DCAS) and its 

dose reconstruction contractor. 

Matters to be Discussed: The agenda 

for the Subcommittee meeting includes: 

discussion of a draft prototype 

document for informing the public on 

completed Subcommittee procedure 

reviews; discussion of the following 

ORAU & OCAS procedures: PER–012 

(‘‘Evaluation of Highly Insoluble 

Plutonium Compounds’’), OTIB–013 

(‘‘Special External Dose Reconstruction 

Considerations for Mallinckrodt 

Workers’’), OTIB–014 (‘‘Rocky Flats 

Internal Dosimetry Co-Worker 

Extension’’), OTIB–019 (‘‘Analysis of 

Coworker Bioassay Data for Internal 

Dose Assignment’’), OTIB–0029 

(‘‘Internal Dosimetry Coworker Data for 

Y–12’’), OTIB–0049 (‘‘Estimating Doses 

for Plutonium Strongly Retained in the 

Lung’’), OTIB–0047 (External Radiation 

Monitoring at the Y–12 Facility During 

the 1948–1949 Period’’), OTIB–0047 

(‘‘Estimating Doses for Plutonium 

Strongly Retained in the Lung’’), OTIB– 

0051 (‘‘Effect of Threshold Energy and 

Angular Response of NTA Film on 

Missed Neutron Dose at the Oak Ridge 

Y–12 Facility’’), OTIB–0054 (‘‘Fission 

and Activation Product Assignment for 

Internal Dose-Related Gross Beta and 

Gross Gamma Analyses’’), OTIB–0054 

(‘‘External Radiation Dose Estimates For 

Individuals Near the 1958 Criticality 

Accident at the Oak Ridge Y–12 Plant’’), 

OTIB–0070 (‘‘Dose Reconstruction 

During Residual Radioactivity Periods at 

Atomic Weapons Employer Facilities’’), 

and TBD 6000 (‘‘Site Profile for Atomic 

Weapons Employers that Worked 

Uranium and Thorium Metals’’); and a 

continuation of the comment-resolution 

process for other dose reconstruction 

procedures under review by the 

Subcommittee. 

The agenda is subject to change as 

priorities dictate. 

This meeting is open to the public, 

but without a public comment period. 

In the event an individual wishes to 

provide comments, written comments 

may be submitted. Any written 

comments received will be provided at 

the meeting and should be submitted to 

the contact person below in advance of 

the meeting. 

Contact Person for More Information: 

Theodore Katz, Executive Secretary, 

NIOSH, CDC, 1600 Clifton Road, 

Mailstop E–20, Atlanta, Georgia 30333, 

Telephone: (513) 533–6800, Toll Free: 1 

(800) CDC–INFO, E-mail dcas@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: May 14, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–12306 Filed 5–20–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Interest Projects (SIPs): SIP 10–029, 

Pilot Study—Cancer Survivorship Care 

Planning & SIP 10–030, Evaluating 

Special Events as a Recruitment 

Strategy for Cancer Screening, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

TIME AND DATE: 8:30 a.m.–6 p.m., June 9, 

2010 (Closed). 


emcdonald on DSK2BSOYB1PROD with NOTICES